ArticleFrontiers in immunology2025

Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome.

Lin Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.